The ability of the long noncoding RNA MEG3 to suppress cell proliferation led to its recognition as a tumor suppressor. MEG3 has previously been shown to bind to p53 in vitro, which led us to hypothesize that MEG3 functions by disrupting the interaction of p53 and its E3 ubiquitin ligase Mdm2. To test this hypothesis in vivo, we built a cross-nearest neighbor/Monte Carlo analytical method based on two color direct stochastic optical reconstruction microscopy (dSTORM), a single-molecule localization microscopy (SMLM) technique. Our data support the interaction of MEG3 and p53. Surprisingly, this association had no effect on the binding of p53 and Mdm2, distinct from the most commonly proposed model for the mechanism of MEG3 action. Additionally, our mathematical approach to analyzing SMLM data has general applicability to assessing molecular interactions in a native cellular context.
INTRODUCTION
The mechanisms by which long noncoding RNAs (lncRNAs) play multiple roles in cellular function are still not well understood. The human MEG3 lncRNA gene is located on chromosome 14q32 and belongs to the conserved, imprinted DLK1-MEG3 locus (Naoki et al., 2000; Zhang et al., 2003) that plays an important role in mammalian growth and development (Takahashi et al., 2009; Takahashi et al., 2010; Das et al., 2015) . MEG3 transcripts are detected in a wide range of normal tissues, including endocrine tissues, brain, gonads, and placenta (Zhang et al., 2003) .
More recently MEG3 has been shown to modulate the activity of multiple miRNAs; for example, MEG3 functions as a decoy for miR-138 (Li et al., 2018) allowing it to regulate the generation of IL-1β in macrophages in models of host defense. MEG3 has also been reported to directly interact with DNA to modulate the transcription of TGF-β pathway genes (Mondal et al., 2015) .
Based on the observation that MEG3 expression is lost in clinically non-functioning pituitary adenomas, we identified MEG3 as a tumor suppressor (Zhang et al., 2003; Zhao et al., 2005; Bauer et al. -Page 3 Gejman et al., 2008; Cheunsuchon et al., 2011) . Compared to normal tissue, MEG3 expression is also significantly reduced or absent in hepatocellular carcinomas (Braconi et al., 2011) , meningiomas (Zhang et al., 2010) , gliomas (Wang et al., 2012) , gastric cancer (Yan et al., 2014) , epithelial ovarian cancer (Sheng et al., 2014) , and squamous cell carcinoma of the tongue (Jia et al., 2014) ; supporting its role as a tumor suppressor. This function was further supported by studies of tumor xenograft growth in nude mice (Wang et al., 2012; Lu et al., 2013; Qu et al., 2013) . Several studies demonstrated that MEG3 expression causes an increase in Cellular tumor antigen p53 (p53, UniprotKB P04637) levels and selectively activates p53 target gene expression (Linares et al., 2003; Zhou et al., 2007; Huang et al., 2011; Lu et al., 2013; Sun et al., 2014) , suggesting that MEG3 functions via p53. However, how the MEG3 lncRNA activates p53 remains elusive.
The mechanisms by which MEG3 and other lncRNAs function on a cellular basis are complex, and different mechanisms can occur simultaneously within one cell. Our previous work indicated that MEG3 functions via activation of tumor suppressor p53 (Zhou et al., 2007) . A transcription factor, p53 coordinates a transcription program to stall the cell cycle, promote DNA repair, and initiate senescence or apoptosis (Ryan et al., 2001) . The primary modulators of p53 activity are E3 ubiquitin-protein ligase Mdm2 (Mdm2, UniprotKB Q00997) and its heterodimer partner Protein Mdm4 (Mdm4, UniprotKB O1515) which constitutively polyubiquitinate p53 for proteasomal degradation, maintaining p53 at low levels Toledo and Wahl, 2006; Perry, 2010) .
Thus, modulating the p53-Mdm2/4 interaction is a critical point of regulation for p53 activity.
Signal-dependent post-translational modification of p53, including phosphorylation and acetylation, can block Mdm2/4 from binding to p53 and prevent its degradation (Bauer et al., 2015) .
Stabilization of p53 may also be achieved through interaction with other proteins such as Peptidylprolyl cis-trans isomerase NIMA-interacting 1 (Pin1) (Zacchi et al., 2002; Zheng et al., 2002) . It has been shown that MEG3 and p53 can be pulled down in one complex by immunoprecipitation (Zhu et al., 2015; Yan et al., 2016) . Therefore, one possible mechanism for p53 activation by MEG3 is disrupting the p53-Mdm2/4 interaction.
To test the hypothesis that MEG3 disrupts p53-Mdm2 binding, we employed direct stochastic optical reconstruction microscopy (dSTORM) single molecule localization microscopy (SMLM) to record the precise positions of MEG3, p53, and Mdm2 in vivo and developed an approach to define and quantify their relationships. The approach characterizes the p53-Mdm2 and p53-MEG3 association by a new cross-nearest neighbor/Monte Carlo algorithm. In contrast to previous models, our data support a model in which MEG3 modulates p53 independently of Mdm2.
RESULTS

Quantifying the associations of MEG3, p53, and Mdm2 by SMLM
The subcellular compartmentalization of lncRNAs like MEG3 is a critical determinant of their mechanism of action. As a result, identifying molecular associations within the spatial context of the cell is necessary to fully define their behaviors. SMLM is exceptionally well positioned to provide this information. SMLM is unique from other microscopy approaches in that it provides high-accuracy coordinates of the positions of fluorophores rather than an image (although an image may be reconstructed from these localizations). As such, SMLM data must be analyzed with very different methods from traditional microscopy data, which are still under active development (Feher et al., 2019) . To use SMLM to examine the binding of MEG3, p53, and Mdm2, we developed an approach that allowed us to identify potentially interacting molecules within cells by calculating the probability that two localizations were anomalously close. We applied a Monte Carlo estimation method that accounts for the local density around a candidate binding pair, partly based on a technique recently introduced for examining the association of sparse mRNAs in neurons (Eliscovich et al., 2017) . Our method is illustrated in Figure 1 . First, nearby localizations were grouped into "molecules" using spatial and temporal thresholds ( Figure 1A, B ). A characteristic of dSTORM is that there is no guarantee that a single molecule will be represented by a single localization. Consider the p53 tetramer: it may be bound by up to 4 primary single-epitope antibodies, each of which may be bound by 1 or 2 secondary antibodies, each of which may have 0-8 fluorophores attached (despite the average being ~1 dye molecule/antibody), and each fluorophore may blink many times before permanent bleaching. A grouping algorithm is important for dSTORM data to remove such autocorrelated localizations for our downstream analysis, which here assumes that each molecule's location is independent of each other molecule.
Second, identified molecules from each channel were paired together through an exclusive cross-nearest neighbor algorithm: closest pair identified then removed, repeating until all possible pairs were made ( Figure 1B and 1C) . The resulting list of pairs is guaranteed to contain all detectable binding events. The third phase of the algorithm assesses the probability that each pair is associated by chance. Within the local neighborhood (radius r = 800 nm, Figure 1D ), 10,000 random permutations of the positions of the molecules within this radius were generated and the smallest paired distance measured in each iteration ( Figure 1E ). The fraction of permutations in which a distance dn less than or equal to the observed distance dmin was recorded as the probability of chance association (p(chance association)) for that molecule pair ( Figure 1F ). These steps were repeated for each pair in each cell, and a graph of distance and probability of chance association may be generated ( Figure 1G ). This plot from a representative cell shows that larger distance is correlated with higher probability of chance association, with wide variability due to local density changes.
Finally, these pairwise measures of association were reduced into a summary figure which would correlate with fraction bound. We considered pairs with a probability of chance association less than 0.1 and a distance of less than 200 nm to be bound, and used that value to generate the final output, fraction bound ( Figure 1H ). In this example, the average distance of the pairs in the "bound" fraction is approximately 50 nm, which corresponds well with the range expected due to the size of the antibody stacks used to detect molecules (up to ~70 nm between fluorophores, Figure 2 ). In this dataset, pairs with a large distance but a low probability of chance association were rare; most of those pairs classified as unbound were due to moderately close pairs in dense areas. 
MEG3-p53 interaction
We developed a group of U2OS osteosarcoma cell clones containing a doxycycline-inducible MEG3 (U2OS-MEG3) and confirmed that MEG3 was induced 100-200-fold on doxycycline treatment as determined by qRT-PCR. We established conditions for simultaneously imaging RNA and protein by combined fluorescence in situ hybridization (FISH) and immunofluorescence (IF) with dSTORM. After 20 h induction with doxycycline, cells were fixed and MEG3 was labeled with a tiled probe set conjugated with Quasar 670 (magenta) and p53 was labeled with a secondary antibody conjugated to ATTO 488 (green). Cells were separately labeled for GAPDH mRNA with a tiled probe set conjugated with Quasar 570 (magenta) as a negative control. Large tiled widefield fluorescence images were taken ( Figure S1 ) and ten individual cells were randomly selected from these fields for dSTORM, in each of three replicates. Representative cells are shown in Figure 3 , widefield (left three columns) and dSTORM localizations and grouped molecules (right two columns, respectively). The intense fluorescence indicating MEG3 is readily apparent in the nucleus of the cells treated with doxycycline, along with p53, while very little MEG3 is apparent in untreated cells ( Figure 3A ). Doxycycline treatment had no apparent effect on the GAPDH mRNA distribution ( Figure 3B ). As seen in the detail of the molecule groups (right column), the grouping operation is slightly biased towards merging nearby clusters.
Using the new cross-nearest neighbor/Monte Carlo method, we found a stark difference between MEG3 and GAPDH mRNA in terms of fraction bound ( Figure 4A ). Two-way nested ANOVA confirmed that the binding fraction was significantly larger for MEG3 than for GAPDH mRNA (F = 19.41, p = 0.002271, ω 2 = 0.3153), but no significant effect due to doxycycline (F = 2.407, p = 0.1594, ω 2 = 0.02410) and no interaction effect (F = 2.400, p = 0.1599, ω 2 = 0.02398).
Since only the RNA main effect was significant, a follow-up one-way nested ANOVA was performed within each RNA type. For GAPDH mRNA, ~4% of p53-GAPDH mRNA pairs were "bound", with virtually no change due to doxycycline (-Dox: 4.26% vs. +Dox: 4.26%; F = 2.134×10 -5 , p = 0.9965, ω 2 = -0.05834) and little variability between cells overall, though significant inter-replicate variability was present (F = 4.448, p = 0.003520, ω 2 = 0.2714) ( Figure   4A , right). There are several reasons why the method has measured some binding between p53 and GAPDH mRNA. First, p53 is known to have promiscuous non-specific RNA binding capacity (Riley and Maher, 2007) . Due to the high overall concentration of molecules in these cells, a few associations may be expected observed by chance. Another contribution may be crosstalk, due to the spectral overlap of the fluorophore used for GAPDH mRNA and p53 (Quasar 570 vs. ATTO 488); localizations would be associated with each other but for a technical and not biological reason. In contrast with GAPDH mRNA, the median fraction of MEG3 bound to p53 as defined by this method was substantially higher at ~9%, and doxycycline induction did not significantly affect this amount (-Dox: 10.21%, +Dox: 7.11%; F = 2.539, p = 0.1863, ω 2 = 0.07640) with wide variability (Figure 4A, left) . No significant effect due to MEG3 induction suggests that the fraction of MEG3 bound to p53 remains constant in vivo across changes in MEG3 expression. For comparison, we also applied a naïve median distance approach, where we calculated the median of the pairwise distances for each cell ( Figure 4B ). In this simple approach, there is a high degree of overlap between MEG3 and GAPDH mRNA distributions (F = 0.3046, p = 0.5961, ω 2 = -0.3323), and increased inter-replicate variability is apparent with this measure (blue, red, orange points; F = 13.53, p = 2.018×10 -13 , ω 2 = 0.5311) ( Figure 4B ). Thus, our cross-nearest neighbor/Monte Carlo-based approach provides a more consistent and robust measure of association over simpler approaches.
MDM2-p53 binding is unaffected by MEG3 expression
To determine whether MEG3 causes accumulation of p53 by disrupting the Mdm2-p53 interaction, MEG3 was induced in U2OS-MEG3 cells, with or without treatment with MDM2-p53 binding inhibitor nutlin-3a. After 24 h of exposure to doxycycline and/or nutlin-3a, cells were fixed.
p53 was labeled with a secondary antibody conjugated to Alexa Fluor 647 (magenta) and Mdm2 was labeled with a secondary antibody conjugated to ATTO 488 (green). Large tiled widefield fluorescence images were taken ( Figure S2 ) and ten individual cells were randomly selected from these fields for dSTORM, in each of three replicates. Representative cells are shown in Figure 5 without much apparent change due to doxycycline. Apparent Mdm2 levels and localization change little between conditions. Individual cells were randomly selected from these fields for dSTORM ( Figure 5 ).
Using the new cross-nearest neighbor/Monte Carlo method, we found that nutlin-3a treatment caused a significant decrease in p53-Mdm2 binding (-Nut: 7.32%, +Nut: 5.10%; F = 6.842, p = 0.03085, ω 2 = 0.1210) ( Figure 6A ). Doxycycline treatment (MEG3 induction) did not have any significant overall effect (-Dox: 5.66%, +Dox: 6.77%; F = 1.719, p = 0.2262, ω 2 = 0.01489). There was no significant interaction effect (F = 0.2855, p = 0.6076, ω 2 = -0.01479). There was significant inter-replicate variability (F = 3.546, p = 0.001105, ω 2 = 0.1784). A follow-up nested one-way ANOVA within the -Nut condition showed a moderate but low-certainty increase in p53-Mdm2 binding with MEG3 induction (F = 2.539, p = 0.1863, ω 2 = 0.0764). Importantly, these data demonstrate that MEG3 does not disrupt p53-Mdm2 binding. For comparison, we again conducted an analysis based on naïve median distances. As with MEG3-p53 binding, we found this simple approach produced overlapping, hard-to-interpret distributions ( Figure 6B ). 
DISCUSSION
We developed a technique to interrogate the interactions and mechanism of MEG3 inside the cell using SMLM. Our technique takes advantage of high-resolution molecule position data to calculate distances between putative binding partners, assesses the probability that the two molecules are not bound together, and thus provides an overall measure of the fraction of pairs of molecules likely bound together. This technique was able to distinguish between non-binding pairs (GAPDH mRNA-p53) and binding pairs (MEG3-p53) in vivo, and detected a robust, linear shift in fraction of Mdm2-p53 bound when a small molecule inhibitor of this interaction, nutlin-3a, was introduced. The evidence obtained through this technique is not consistent with the prior hypothesis that MEG3 acts by protecting p53 from polyubiquitination by Mdm2, as induction of MEG3 was not accompanied by a decrease in Mdm2-p53 binding. Moreover, the fraction of binding assessed between MEG3 and p53 indicates that far too few stable interactions are occurring to effectively inhibit Mdm2-p53 binding. These data suggest that MEG3 activates p53 through alternative mechanisms. Under MEG3 induction, p53 transcription activation is selective, inducing certain targets (e.g., GDF15) but avoiding others (e.g., CDKN1A) (Zhou et al., 2007) . It may be that the MEG3-p53 heterodimer fails to strongly induce Mdm2 expression, thereby suppressing the negative feedback regulatory loop. MEG3 also interacts with the chromatin remodeler Polychrome repressive complex 2 (PRC2) (Zhao et al., 2010; Kaneko et al., 2014) , which is responsible for forming heterochromatin at target sites. MEG3 targets PRC2 to certain sites via DNA triplex formation (e.g., TGF-β pathway genes) (Mondal et al., 2015) and protects other sites from PRC2 activity (e.g., MEG3 locus) (Das et al., 2015) . A recent investigation of MEG3 structure identified a pseudoknot critical for p53 activation, which however was not involved in p53 binding (Uroda et al., 2019) . It is also possible that MEG3 may modulate the activity of Mdm2 on p53 by forming a ternary complex with them. Similar interactions have been observed with p14 ARF (Tumor suppressor ARF) (Savchenko et al., 2008) , UCH-L1 (Ubiquitin carboxyl-terminal hydrolase isozyme L1) (Li et al., 2010) , and the 5S RNP (Sloan et al., 2013) . Future work will need to address these alternative mechanisms.
There are some important challenges to the in vivo SMLM-based binding analysis we have developed, and which affect SMLM analysis approaches in general. First, despite the 10-20 nm resolution of each localization, the large distance between the molecule of interest and the fluorophore greatly limit the analytical resolution. A typical two-antibody stack can have a displacement of up to ~35 nm from the bound epitope to the conjugated fluorophore; thus, the fluorophores for a bound pair of molecules may be separated by 70 nm or more (Figure 2) , depending on the distance between epitopes. In addition, the antibody stack may be free to rotate and flex at the neck, adding variability in the position of the fluorophore during imaging (Saphire et al., 2002) . These distance issues may be addressed in part using F(ab)′ fragments or nanobodies (small single-domain antibody fragments derived from camelids) (Carrington et al., A second set of limitations comes from the stochastic nature of SMLM. Fluorophores may blink many times, only once, or not at all (Annibale et al., 2011) . This phenomenon makes it difficult to distinguish between nearby molecules of the same type. We employed an aggressive grouping algorithm to address this issue, but the tradeoff is that true separate molecules may be missed.
We labeled our own secondary antibodies to control the dye:antibody ratio at ~1:1 to limit multiple blinking, but the labeling creates a distribution and some antibodies will still have multiple fluorophores. Antibodies engineered to have consistent labeling stoichiometry would be an improvement. A trade-off to limiting the dye:antibody ratio is that many of the secondary antibodies will have no fluorophore, reducing labeling efficiency. SMLM techniques generally have shown a labeling efficiency of at most 60% (Feher et al., 2019) , which means that rare binding interactions may be hard to detect.
A third challenge for SMLM comes from drift. Autocorrelation drift correction is standard, but it is optimal for defined structures that can be aligned from repeated blinks that occur throughout the acquisition. Singular soluble proteins, which blink only within a small window, pose a challenge for this correction method, and too few blinks overall can prevent the algorithm from working despite apparent drift by eye. Further, this correction method cannot remove high-frequency variation in position through vibration within the microscope. Fluorescent beads may be used as a fiducial marker at the coverglass surface, but a solution is needed that would work throughout the cell. A sparsely labeled ubiquitous cellular structure, like tubulin, could serve this purpose with an appropriately engineered label.
Combined, the improvements discussed above would greatly increase the effective analytical resolution for detection of binding events in vivo. Our cross-nearest neighbor/Monte Carlo analytical approach could easily be extended to 3-dimensional STORM data and multi-protein complexes with three-color STORM. However, care would need to be taken to avoid crosstalk between adjacent fluorescence channels as it would generate false positives.
Previously, we found that MEG3 induces p53 stabilization and stimulates p53-dependent transcription activation (Zhou et al., 2007) . We also observed that p53 activated by MEG3 selectively upregulates GDF15, but not p21 CIP1 (Zhou et al., 2007) . In this study, we demonstrated that MEG3 lncRNA interacts with p53 in vivo and can be detected with a novel analytical method using dSTORM. We also demonstrated that the p53-Mdm2 interaction is not disrupted by MEG3 in vivo. Taken together, these data suggest that MEG3 activates p53 by an alternative mechanism that is yet to be determined. Finally, we believe our in vivo binding analysis provides a powerful new tool to assess macromolecular interactions in a native cellular context.
MATERIALS AND METHODS
Cell lines, media, and growth conditions
The U2OS osteosarcoma cells (ATCC HTB-96) were maintained in Dulbecco's modified Eagle's medium (DMEM) (Gibco 11995065) supplemented with 10% heat-inactivated FBS (Gibco A3060502), glutamine (2 mM), penicillin (100 U/mL), and streptomycin (0.1 mg/mL) (Gibco 10378016) at 37 °C and 10% CO2. Doxycycline (Dox; 1 µg/mL) was added to media for at least 20 h to induce expression of the transfected tetracycline-inducible MEG3. Nutlin-3a (Nut; 10 µM) was added to media for at least 24 h to inhibit Mdm2-mediated degradation of p53. For microscopy, 3-5×10 4 cells were seeded into each well of a chambered 8-well 1.5H coverglass (Ibidi 80827) and allowed to adhere overnight prior to further manipulation. Cells were tested for mycoplasma contamination every three months. U2OS-MEG3 cells were regularly authenticated by qRT-PCR and/or FISH for induction of MEG3 by doxycycline.
Bauer et al. -Page 15
Plasmid construction and transfection
A modified Tet-On expression system was used to express MEG3, consisting of pBiTetO-MEG3-GFPLoxP and pCMV-rtTA3-IRESpuro. pBiTetO was constructed by replacing the CMV promoter in expression vector pCI with a tetracycline-responsive bi-directional promoter, BiTetO, which was synthesized to contain 7 modified TetO elements flanked by two minimal CMV promoter sequences based on pTet-T2 sequences (GenScript) (Loew et al., 2010) . To facilitate selection of clones, a GFP cDNA in with the coding region flanked by two LoxP sites was cloned into pBiTetO to generate pBiTetO-GFPLoxP. The MEG3 cDNA in pCI-MEG3 (Zhou et al., 2007) was modified by replacing AATAAA and its downstream poly(A) tail with a genomic DNA fragment containing the MEG3 gene polyadenylation signal. The resultant MEG3 cDNA was then cloned into pBiTetO-GFPLoxP to generate pBiTetO-MEG3-GFPLoxP. To construct pCMV-rtTA3-IRESpuro, a modified tetracycline responsive transactivator (rtTA3) was synthesized with changes in three amino acids including F67S, F86Y, and A209T (Das et al., 2004; Zhou et al., 2007) and inserted into pIRESpuro3 (Clontech Laboratories). Plasmids were verified by sequencing.
For stable transfection, U2OS cells were seeded into 6-well cell culture plates and transfected with pBiTetO-MEG3-GFPLoxP and pCMV-rtTA3-IRESpuro at a ratio of 3 to 1 using Mirus TransIT-LT1 according to the manufacture's instruction. Forty-eight hours after transfection, cells were re-seeded in P100 dishes with limited dilution. Approximately ten days after treatment with puromycin (2 µg/mL), drug resistant colonies were isolated using cloning rings. Cells from individual clones were treated with or without doxycycline (1 µg/mL) for 24 h. GFP expression was evaluated under a fluorescence microscope. Cells expressing GFP in Dox-treated wells were further examined for MEG3 expression by qRT-PCR. Two sets of primers were used to detect MEG3. The first set detected a fragment near the 5′ end of the MEG3 cDNA: 5′-ATTAAGCCCTGACCTTTGCTATGC-3′ (forward) and 5′-ATAAGGGTGATGACAGAGTCAG-TCG-3′ (reverse); the second set detected the 3′ end of the MEG3: 5′-CTTCAGTGTCTGCATGTGGGAAG-3′ (forward) and 5′-TGCTTTGGAACCGCATCACAG-3′ (reverse). The GAPDH gene was used as an internal reference. The primers for detection of GAPDH were: 5′-GATGACATCAAGAAGGTGGTGAAGC-3′ (forward) and 5′-CGTTGTCATA-CCAGGAAATGAGCTTG-3′ (reverse). Cell clones with suitable MEG3 induction were treated with adenoviruses expressing Cre (Ad-Cre) to remove the floxed GFP. Up to three rounds of virus treatments were needed to completely remove GFP. The removal of GFP was confirmed by qRT-PCR with primer set: 5′-CCACAACGTCTATATCATGGCCG-3′ (forward) and 5′-GTGCTCAGGT-AGTGGTTGTCG-3′ (reverse). A total of four clones containing inducible MEG3 were finally obtained and designated as U2OS-MEG3.
Direct stochastic optical reconstruction microscopy (dSTORM)
Fixation
Cells were grown to between 30-90% confluence in chambered coverglass. Cells were rinsed with prewarmed Dulbecco's phosphate-buffered saline with calcium and magnesium (DPBS;
Corning) twice using near-simultaneous aspiration and injection of liquid to avoid dehydration.
Prewarmed fixation buffer (4% (v/v) paraformaldehyde (Electron Microscopy Sciences), 0.1% (v/v) glutaraldehyde (Electron Microscopy Sciences)) was added and incubated in the dark for 15 min. [2A10] (Abcam ab16895, Lot GR324625-5)) were applied at 1:1000 and 1:200 dilutions, respectively, in blocking buffer and incubated overnight at 4 °C. Cells were washed with DPBS 6 times for 5 min each. Secondary antibodies (donkey anti-rabbit IgG (Jackson ImmunoResearch) and donkey anti-mouse IgG (Jackson ImmunoResearch)) were labeled as previously described with ATTO 488 (ThermoFisher Scientific) or Alexa Fluor 647 (ThermoFisher Scientific) for a dye ratio of ~1:1 (Schmider et al., 2019) . Secondary antibodies were added at 3 μg/mL each in blocking buffer and incubated for 2 h at room temperature in the dark. All subsequent steps were performed in the dark. Cells were washed with DPBS 6 times for 5 min each. Antibody stacks were crosslinked by 4% (v/v) paraformaldehyde in DPBS for 15 min. Remaining fixative was quenched and washed with DPBS-G twice for 5 min each, followed by DPBS twice for 5 min each.
Stained cells were stored at 4 °C for up to 2 weeks before imaging.
Combined immunofluorescence and fluorescence in situ hybridization (FISH)
All buffers are RNase-free. Cells were permeabilized with 0.2% Triton X-100 in RNase-free PBS (Corning) for 10 min and rinsed with PBS. No blocking was performed to avoid introducing RNase activity. Primary antibody (rabbit anti-p53, see above) were applied at 1:1000 or 1:200 dilutions, respectively, in PBS and incubated overnight at 4 °C. Cells were washed with PBS 6 times for 5 min each. FISH was performed using buffers and ~20-mer tiled probe sets from Stellaris, according to manufacturer's protocol. In brief, cells were washed with Wash Buffer A 2 times for 3 min. MEG3-Quasar 670 (Stellaris, custom order) or GAPDH-Quasar 570 (Stellaris SMF-2026-1) probe mixture was mixed 1:1000 in Hybridization Buffer and 100 µL was added per well. Steps from this point forward were conducted in the dark. The chambered coverglass was placed in a pre-warmed humidified chamber (large culture dish with damp paper towels) and incubated at 37 °C for 16 h. Cells were washed 2 times for 15 min each with warm Wash Buffer A in the humidified chamber. Secondary antibodies (donkey anti-rabbit conjugated with ATTO 488, see above) were added at 3 μg/mL each in Wash Buffer A and incubated for 1 h at 37 °C in the humidified chamber. Cells were washed 2 times for 2 min each with Wash Buffer B, then 2 times for 5 min each with PBS.
Imaging
Imaging buffer containing 10 mM cysteamine (2-mercaptoethylamine, MEA; Sigma-Aldrich), 3 U/mL pyranose oxidase from Coriolus sp. (Sigma P4234), and 90 U/mL catalase was freshly prepared in STORM buffer. Cysteamine stock solution was previously titrated to pH 8 and aliquots frozen. Precipitate in pyranose oxidase/catalase 100x enzyme stock solution was cleared by centrifugation at over 14,000×g prior to use. STORM buffer was composed of 10% (w/v) glucose, 10 mM sodium chloride, and 50 mM Tris hydrochloride (pH 8.0). We found the pyranose oxidase buffer (first described in (Swoboda et al., 2012) ) to be superior to the standard glucose oxidase buffer. This buffer allowed longer imaging times due to minimal pH change, and the enzyme stock lasted several months at 4 °C with no observable decline in imaging quality. 10 mM cysteamine was selected for superior imaging characteristics with different dyes (van de Linde et al., 2011) .
PBS was replaced with the imaging buffer and the slide was mounted on the stage with type F immersion oil (refractive index = 1.515) on a Nikon Ti2 Eclipse inverted microscope. The 1 s exposure using GFPHQ, TexasRedHYQ, or Cy5HYQ filter cubes, from which random individual cells were selected for dSTORM imaging. At least 11000, 256x256 pixel (160 µm/pixel) frames were collected with 10 ms exposure time at 100% laser power with lasers in highly inclined and laminated optical sheet (HILO) configuration (Tokunaga et al., 2008) . Each channel was collected sequentially from longest wavelength the shortest.
Data analysis
Localizations were identified from STORM image stacks using Nikon Elements 5.0 (NSTORM 4.0), with a peak height threshold of 250. Localization lists were exported as tab-delimited text files.
Localization data was processed with custom code written in the freely available Julia scientific computing language (v1.2) (Bezanson et al., 2017) . Localizations identified in the first 100 frames, while fluorophores are being placed into the "off" state, were excluded. Localizations identified in the last 10 frames were also excluded due to artifacts caused by the change in optical configuration. For each image, a grouping algorithm (SI Algorithm 1; Figure S3 ) was applied to each channel to combine repeated blinking from single fluorophores and localizations that may be associated (e.g., another fluorophore on same secondary antibody, another secondary antibody on the same primary antibody, another primary antibody on a multimer). The first stage of the grouping algorithm iteratively identified local density maxima by searching a 34.2 nm radius and within a temporal window of 500 frames (5.0 s) of each localization for the localizations with the most neighbors, combining those localizations within the radius of the maxima, and repeating until all localizations were assigned to a group. The 34.2 nm radius limit was derived from a simulation of the possible orientation and positions of fluorophores in an antibody stack, to account for possible motion of the antibody stack and multiple fluorophores on the stack. The temporal window was applied to account for longer-scale on/off cycles of the fluorophores, as first described for PALM data (Annibale et al., 2011) , and was chosen semi-empirically by testing a range of values and selecting the smallest value that merged the most localizations (i.e., where the slope starts to decrease before the plateau) ( Figure 7A ) and where the merge results appeared suitable (e.g., few temporally separated clusters of localizations were merged).
In the second stage, grouped localizations were merged if they were found within 200 nm of each other by a similar local density maxima search algorithm to further reduce redundancy from autocorrelated localizations. The products of this grouping algorithm were termed "molecules."
The position of the resulting molecule was the mean of its component localizations' positions, and its linear localization accuracy was the mean of the accuracy for its component localizations divided by the square root of the number of component localizations.
The molecules were paired between channels by an exclusive cross-nearest neighbor algorithm (i.e., closest pair found and then removed, next closest pair found and then removed…; SI Algorithm 3) to obtain a distance distribution between the two sets of molecules. Two analytical approaches were applied, simple and sophisticated. First, the median paired distance was calculated for each cell. Second, a novel approach was developed to control for local density, based on a similar approach applied to single-molecule conventional fluorescence microscopy (Eliscovich et al., 2017) . Random permutations (10,000) of the molecules in the local (800 nm radius) neighborhood around each potential binding pair were generated and the closest pairwise distance in each permutation was calculated to create a Monte Carlo estimation of the distribution of distances due to local density (SI Algorithm 4). The local neighborhood radius of 800 nm was semi-empirically chosen based on testing multiple window sizes with the algorithm and choosing the value that provided a balance of sensitivity (smaller value) and robustness (less inter-sample change as parameter changes) ( Figure 7B ). The fraction of permutations with a closest distance less than the observed distance was the percentile rank score, indicating the probability of chance association given the local density of both molecule types. Finally, the fraction of pairs within the maximum binding distance (200 nm) and with a probability of chance association of less than 0.1 was calculated for each cell. The maximum binding distance was chosen based on knowledge of the size of the target molecules (up to 20 nm across) and the size of the antibody stacks (up to 70 nm), with allowance for error. These data were analyzed by two-way fixed-factor ANOVA with 2 nested factors (cells within replicates within conditions), with α = 0.05, using the SimpleANOVA.jl (v0.6.0) Julia package created by the authors. Data was checked for extreme outliers, heteroscedasticity, and normality of residuals, and were determined to be reasonable. Plots were generated with StatsPlots.jl (v0.12.0) and assembled with Adobe Illustrator 24.0.
Code availability
All the code generated specifically for this manuscript is written in the Julia language and available in the repository at https://github.com/BioTurboNick/SMLMAssociationAnalysis_NCB.jl.
Supporting packages can be obtained within Julia from its public package registry.
